Impaired immunosuppressive effect of bone marrow mesenchymal stem cell-derived exosomes on T cells in aplastic anemia

Shichong Wang1,2, Jiali Huo1, Yilin Liu1

  • 1Diagnostic and Therapeutic Center for Anemic Diseases, State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, 300020, China.

PubMed
Abstract

Insights

Exosomes from aplastic anemia patients' mesenchymal stem cells (AA-Exos) show impaired immune suppression and therapeutic effects compared to healthy donor exosomes (HD-Exos). These AA-Exos exhibit altered miRNA profiles, suggesting a role in aplastic anemia pathogenesis and potential therapeutic targets.

Area of Science:

  • Immunology and Stem Cell Biology
  • Molecular Medicine
  • Hematology

Background:

  • Mesenchymal stem cells (MSCs) dysfunction in immunoregulation is known in aplastic anemia (AA) patients.
  • Exosomes from MSCs can mediate immune regulation, but their dysfunction in AA may contribute to immune dysregulation.
  • AA-derived MSC exosomes (AA-Exos) may play a critical role in the immunologic dissonance observed in aplastic anemia.

Purpose of the Study:

  • To compare the immunosuppressive effects of exosomes derived from AA-MSCs (AA-Exos) and healthy donor MSCs (HD-Exos) on T cells.
  • To evaluate the therapeutic efficacy of AA-Exos versus HD-Exos in an immune-mediated murine model of AA.
  • To investigate the molecular mechanisms, including miRNA-mRNA interactions, underlying the functional differences between AA-Exos and HD-Exos.

Main Methods:

  • Co-culture of CD3+ T cells with AA-Exos and HD-Exos to assess T cell proliferation, differentiation, and activation.
  • Establishment of an immune-mediated murine model of AA to compare the therapeutic effects of AA-Exos and HD-Exos.
  • RNA sequencing (RNA-seq) of exosomes and T cells to construct a miRNA-mRNA interaction network and perform functional analysis.

Main Results:

  • AA-Exos demonstrated impaired inhibition of CD3+ T cell proliferation, activation, and differentiation compared to HD-Exos.
  • HD-Exos showed superior therapeutic rescue in AA mice compared to AA-Exos.
  • Differentially expressed miRNAs (e.g., miR-199, miR-128, miR-486) and altered pathways (e.g., graft-versus-host disease, Th17 cell differentiation, JAK-STAT signaling) were identified, with a constructed miRNA-mRNA network.

Conclusions:

  • AA-Exos exhibit diminished immunosuppressive capacity on T cells and reduced therapeutic potential in AA models.
  • Altered miRNA profiles in AA-Exos may contribute to AA pathogenesis.
  • Dysfunctional AA-Exos represent a potential therapeutic target for aplastic anemia treatment.

Related Concept Videos

Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.1K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
345
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
68.7K